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The pathophysiology of acne vulgaris depends on active sebaceous glands, implying that selective destruction of
sebaceous glands could be an effective treatment. We hypothesized that light-absorbing microparticles could be
delivered into sebaceous glands, enabling local injury by optical pulses. A suspension of topically applied gold-
coated silica microparticles exhibiting plasmon resonance with strong absorption at 800 nm was delivered into
human pre-auricular and swine sebaceous glands in vivo, using mechanical vibration. After exposure to 10–
50 J cm− 2, 30 milliseconds, 800 nm diode laser pulses, microscopy revealed preferential thermal injury to
sebaceous follicles and glands, consistent with predictions from a computational model. Inflammation was mild;
gold particles were not retained in swine skin 1 month after treatment, and uptake in other organs was negligible.
Two independent prospective randomized controlled clinical trials were performed for treatment of moderate-
to-severe facial acne, using unblinded and blinded assessments of disease severity. Each trial showed clinically
and statistically significant improvement of inflammatory acne following three treatments given 1–2 weeks apart.
In Trial 2, inflammatory lesions were significantly reduced at 12 weeks (P= 0.015) and 16 weeks (P= 0.04)
compared with sham treatments. Optical microparticles enable selective photothermolysis of sebaceous glands.
This appears to be a well-tolerated, effective treatment for acne vulgaris.
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INTRODUCTION
Acne vulgaris is the most common dermatological disease,
especially afflicting adolescents. It can cause permanent facial
scarring and negative psychosocial impact (Williams et al.,
2012). Acne lesions consist of closed and open comedones,
inflammatory papules, pustules, nodules, and cysts, originating
from individual sebaceous follicles. A sebaceous follicle has an
enlarged infundibulum, large multilobular sebaceous gland
with multiple ducts, and a tiny hair (Kligman, 1974). The
pathogenesis of acne is multifactorial and includes overactive
sebaceous glands, follicular hyperkeratinization, immunologi-
cal changes, plugging of the infundibulum facilitating P. Acnes
bacteria colonization, and inflammation. Topical and oral drug
therapies for acne are available, with limited efficacy. Oral
isotretinoin, which inhibits sebaceous gland activity, reduces
the sebum excretion rate and hyperkeratinization, causes
modification of the extracellular matrix, and is highly effect-
ive (Peck et al., 1979, Strauss et al., 1980, Papakonstantinou
et al., 2005) but is associated with local and systemic side
effects and is teratogenic.
Alternatively, there has also been a significant interest in deve-
loping light-based treatments for acne. Photodynamic therapy,
using long incubation (≥3 hours) topical 5-aminolevulinic acid
followed by high fluence red light exposure, like oral isotretinoin,
can directly inhibit sebaceous gland function via sebocytes
destruction and improve acne (Hongcharu et al., 2000, Kosaka
et al., 2006, Sakamoto et al., 2010). However, high-dose photo-
dynamic therapy with red light is associated with side effects
such as intense pain during irradiation, long-lasting erythema,
oozing, and crusting. Intense blue light has been shown to
improve inflammatory acne, by unknown mechanisms (Elman
et al., 2003; Omi et al., 2004). However, efficacy is modest;
multiple treatments are necessary; and recurrence is common.
To date, the use of light-based treatments for acne has
been limited (Webster, 2010). Selective photothermolysis
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(Anderson and Parrish, 1983) of sebaceous glands and
sebaceous follicles is a promising paradigm for successful
treatment of acne, if it can be localized to the follicles, with a
similar mechanism of action as light-based removal of
pigmented hair and abnormal blood vessels. Optical pulses
from a free-electron laser at the 1,720 nm mid-infrared
absorption band of lipids in sebum were able to selectively
damage sebaceous glands within human skin ex vivo
(Anderson et al., 2006; Sakamoto et al., 2012). However,
there is a narrow range of conditions for selective injury to the
glands, and no adequate conventional light sources at these
wavelengths are currently available.
Anderson suggested that selective photothermolysis of
sebaceous glands could be achieved by first introducing a
light-absorbing chromophore into sebaceous follicles fol-
lowed by exposure to optical pulses (Anderson, 1999). This
method would potentially target overactive sebaceous glands
and hyperkeratinizing cells of the infundibulum that have a
role in acne pathophysiology. Local heating of the
microenvironment where P. Acnes proliferate may also
reduce bacteria in the follicle. As with laser or flashlamp-
induced permanent hair reduction, laser-induced permanent
sebum reduction may also be possible. Lloyd and Mirkov
(2002) reported a pilot study of sebaceous gland heating and
improvement in acne using topical indocyanine green
followed by light exposure. The infundibular opening and
the infundibulum are a natural ingress to the sebaceous duct
and gland; delivery of particles into follicles has been reported
with massage as an assist with recent work by Patzelt
indicating deep penetration with ~ 645 nm particle size
(Rolland et al., 1993; Toll et al., 2004; Lademann et al.,
2007; Patzelt et al., 2011).
In this work, inert microparticles invented by Oldenburg
et al., (1998) and Halas (Hirsch et al., 2006) are chosen. These
microparticles are designed for surface plasmon resonance
and strong near-infrared absorption. Surface plasmon reso-
nance occurs when there is resonance between the incoming
electromagnetic field and modes of electron conduction
within the particles. Microparticles with 120 nm diameter
silica core and 15 nm thick gold shell were selected, as they
provide a strong optical absorption at ~ 800 nm. The particle
size distribution is narrow, with polydispersity index of 0.10.
This wavelength corresponds to a widely used hair removal
source and provides deep penetration to the sebaceous glands
depth (40.5–1.5mm). The extinction cross-section of these
particles is large (Jain et al., 2006), on the order of 10− 13 m2,
~ 5 times larger compared with their physical cross-section.
The particles collect light from paths outside their physical
boundary, and a low concentration of particles in the target
leads to a strong optical absorption.
We have addressed three questions: (1) what is the
biodistribution of gold microparticles after topical application
and delivery into sebaceous follicles? (2) can particles be
delivered in adequate concentration to allow typical 800 nm
laser irradiation parameters to cause local thermal damage to
sebaceous follicles and glands? (3) does selective thermal
damage to sebaceous follicles lead to improvement in facial
acne? The questions are answered by a systematic, step-wise
approach of (a) delivery of gold microparticles and selective
photothermolysis in an in vivo animal model (pig skin), (b)
safety in a porcine model, (c) histopathology of follicles in
post-auricular human skin, and d) clinical trials demonstrating
efficacy.
RESULTS
Gold microparticle delivery and selective photothermolysis
The swine ear experiments demonstrated that microparticles
can be delivered into sebaceous follicles and glands, resulting
in local thermal injury after laser exposure. Topically applied
gold microparticles assisted by massage led to uptake in
sebaceous follicles. Supplementary Figure S1 online shows a
photograph taken via a dissecting microscope where the dark
stain indicates the presence of the gold microparticles.
Figure 1 illustrates selective photothermal damage to infundi-
bulum and sebaceous glands of in vivo pig skin, in immediate
post-treatment biopsies. Supplementary Figure S2 online
shows selective loss of nitro-blue tetrazolium chloride (a
lactate dehydrogenase activity stain) around the follicle and
majority of the gland (delineated by a dotted black line) from
another immediate post-treatment biopsy, indicating photo-
thermal damage.
Computational model of fluence distribution, optical
absorption, and thermal tissue injury
Thermal injury to sebaceous follicles was consistent with
results of the computational model. Even with the conserva-
tive assumption of ~ 3% of applied particle concentration in
sebaceous follicles, selective heating of sebaceous glands was
predicted. The temperature versus depth through the central
axis, in which the sebaceous gland is located, is shown in
Supplementary Figure S3 online. The peak temperature of the
gland, with a 10 J cm− 2 pulse, is ~ 85 °C, enough to produce
significant thermal injury. Amount and spatial distribution of
Figure 1. Photomicrographs of hematoxylin and eosin stained sections
showing selective thermal damage to the infundibulum and sebaceous gland
of a follicle in in vivo pig skin, immediately post treatment. The black outline
delineates the tissue areas with thermal damage. Scale bar represents 0.2 mm.
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the local thermal damage can be modulated by controlling
the amount of particles delivered, incident fluence, and pulse
duration (data not shown). In particular, the pulse duration
can be increased to expand the zone of thermal damage, and
the incident fluence and/or particle concentration can be
increased for higher intensity of thermal damage.
Biodistribution and skin safety studies in an in vivo porcine
model
Minimal erythema and edema were observed immediately post
treatment. No blisters, burns, or scarring was noted. No signs of
pain or systemic abnormalities were observed. Complete blood
count, serum chemistries, and necropsy findings including
organ histology were normal. Two months after treatment, the
skin was normal, and histology showed focal changes limited
to sebaceous follicles. The stable, inert microparticles taken
into sebaceous follicles are apparently excreted from the
follicles over time. Cutaneous gold concentration at various
time points for the two treatment animal (Table 1) returned to
baseline levels by 1 month post treatment. The highest level of
gold in any organ following two treatments was 40.5 ng g−1,
much lower compared with the established safety threshold of
3,000 ng g−1 (Gad et al., 2012).
Histopathology after treatment of post- and pre-auricular in vivo
human skin
Histology of immediate post-treatment biopsies showed local
thermal injury to the infundibulum in 84% (27/32) and injury
to sebaceous gland in 47% (15/32) of the specimens. The
maximum depth of the thermal injury was 1.43mm, with an
average depth of 0.47 mm. The adjacent dermis and the
epidermis did not show damage. Figure 2 is a collage of
sebaceous follicles, showing typically observed patterns of
thermal damage to the infundibulum, sebaceous duct, and
glands. In one example, complete glandular destruction is
noted. The mid-follicular region, so-called bulge region,
where epithelial stem cells reside (Cotsarelis et al., 1990;
Panteleyev et al., 2000), often appeared damaged.
Trial 1: Randomized, controlled clinical trial of facial acne
At 12 weeks, the mean absolute inflammatory lesion count
decreased significantly by 14.3 in the treated population versus
5.1 in the control population (P=0.009). Temporal evolution
of mean percent reduction in inflammatory lesion counts is
presented in Figure 3a for both populations. The mean percent
inflammatory lesion count change continued to decrease and
reached −61% at 28 weeks post baseline for treatment arm
subjects. Figure 4 shows baseline and 24-week follow-up
photographs of a subject in the treatment arm. There were no
severe side effects, and the treatment was well tolerated with a
mean pain score of 3.9. Erythema and peri-follicular edema
were noted in some subjects, lasting o30 minutes.
Trial 2: Randomized, controlled clinical trial of facial acne
Forty-nine of the 51 subjects completed treatments and
follow-up evaluations. Figure 3b shows the mean percent
reduction from baseline in inflammatory lesion count at
various time points for the two arms. A statistically significant
difference in reduction was noted at each point between the
two arms. At 12-week post baseline, the mean percent
inflammatory lesion count changes were −49.0% and
−21.7% for the active treatment and sham arms, respectively
(P=0.015). Also, at 16-week post baseline, changes were
−53% and −30% for the active treatment and sham arms,
respectively (P=0.04). Supplementary Figure S4 online shows
baseline and 12-week follow-up photographs of a subject in
the treatment arm. At 12-week post baseline, 40% of subjects
in the treatment arm, whereas none in the sham arm, showed
Investigator’s Global Assessment (IGA) score reduction in
two or higher. Response rates (50% or higher reduction in
inflammatory lesions) at each follow-up point are shown
in Supplementary Figure S5 online. Treatment was well
tolerated, with a mean pain score of 3.5 in the active treat-
ment group. The CONSORT flowchart for this trial appears in
the Supplementary Information online.
DISCUSSION
Optical particle-assisted selective photothermolysis shows
good promise for acne treatment. To our knowledge, this is
the first report that topically applied that light-absorbing
particles can be used to mediate selective photothermolysis of
sebaceous follicles, which in turn provides an effective and
well-tolerated treatment for acne vulgaris. First, we found that
vibratory massage is capable of introducing small particles
deeply into the infundibulum and gland of sebaceous
follicles, in swine, and in humans on the face. Gold-
covered silica particles with maximal optical absorption at
800 nm, a common near-infrared wavelength for laser hair
removal, were chosen. The particles exhibit plasmon reso-
nance, a phenomenon in which conduction electrons are
excited in resonance with the incoming electromagnetic field,
to create very strong optical absorption. After delivery of the
particles into sebaceous follicles and exposure to 800 nm
diode laser, we found selective thermal injury in sebaceous
follicles of both swine and humans, in accordance with the
principles of selective photothermolysis. In two prospective,
controlled clinical trials on the face, three treatments given
within 1 month using this approach produced significant
improvement of inflammatory acne; and the improvement
persisted for months.
Table 1. Table of average gold concentration in
ng gm−1 in the skin at various time points measured
with the Neutron Activation Analysis quantitative
technique
Time-point
Average measured gold
concentration (ng gm− 1)
Pre-treatment (baseline) 215.3
Immediate post Treatment 1 6,842.4
3 Weeks, post Treatment 1 921.7
Immediate post Treatment 2 4,518.6
14 Days post Treatment 2 1,096.9
1 Month post Treatment 2 180.0
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Selective photothermolysis is a mainstay for treatment of
cutaneous vascular lesions, benign pigmented lesions, tattoo
removal, and permanent hair reduction. Of these, only in
tattoos is the chromophore an exogenous, light-absorbing
nanoparticle. In contrast to the particle-assisted laser acne
treatment reported here, the particles of tattoos are intracel-
lular and are permanently embedded in the dermis. In this
study, we delivered particles topically and introduced them in
the open pores and ducts within sebaceous follicles. The
particles that we used are colored, stable, and inert, like tattoo
particles. We were initially concerned that damage to the
sebaceous follicles could release these particles into the
surrounding dermis, causing a tattoo. Fortunately, this did not
occur—residual particles were not detectable 1 month after
treatment in swine—and no tattooing was observed after
treatment in either swine or humans. The damaged follicle
and particles were apparently eliminated from the skin, in
small crusts similar to those seen after treatments for laser hair
removal or fractional laser treatments.
Potential advantages of particle-assisted laser acne treat-
ment include a lack of systemic toxicity, minimal local
inflammatory side effects, efficient reduction in acne severity
after a brief well-tolerated procedure, and long-lasting
therapeutic benefit. Potentially, permanent improvement of
acne may be achieved (as in laser hair reduction), but at
present this is unknown. Another potential advantage over
medical therapies for acne is that particle-assisted selective
photothermolysis is an office-based procedure and does not
depend on patient compliance.
Many questions remain to be answered. The pace and
mechanisms of sebaceous gland recovery after local thermal
damage are unknown. Size, composition, formulation, and
delivery of the particles could probably be further optimized.
Potentially, other kinds of particles or substances and other
Figure 2. Collage of photomicrographs of immediate post-treatment pre- and post-auricular human skin biopsies showing examples of thermal damage to the
infundibulum and sebaceous gland (hematoxylin and eosin stain). The black arrows point to the areas of thermal damage. Scale bar represents 0.1 mm.
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laser wavelengths could be used. Laser fluence and pulse
duration in our clinical trials were chosen based on the
preclinical studies. We did not perform dose-response (for the
particles) or fluence-response (for the laser) studies of acne
improvement. We did not test a single treatment, nor a longer
series of treatments; it is possible that similar efficacy can be
seen with less than three treatments. The pilot clinical trials in
this study were prospective, controlled, quantitative and
randomized but are limited by the number of subjects.
Despite this limitation, it is clear that topically applied, light-
absorbing particles can be delivered into sebaceous follicles,
followed by exposure to pulses of light, leading to selective
photothermolysis, as a safe and effective treatment for acne
vulgaris.
METHODS AND MATERIALS
Gold microparticles were manufactured by Nanospectra
(Houston, TX) and were placed in suspension at Dow
Pharmaceutical Sciences (Petaluma, CA). The suspension
had a nominal Optical Density of 250 at 1 cm path length and
an absorption coefficient of 345 cm− 1 at 800 nm.
Delivery into follicles of ex vivo and in vivo animal skin
Pig ear skin, rich in sebaceous glands (Sakamoto et al., 2009),
was chosen as a model. Fresh-frozen ears were thawed and
hair was epilated. Several penetration-assist methods includ-
ing massage, iontophoresis, pressure pulsing, and ultrasound
were tested. Massage was chosen, given its performance and
practicality. Suspension (2 ml) was dripped over a 2× 6 cm
area and massaged (Hitachi Magic Wand, setting “high”) for
2 minutes. Suspension remaining on the skin was wiped with
gauze, leaving particles within the follicles. Irradiation
(9× 9mm spot, 30–50 J cm−2, 30 milliseconds duration,
~ 10% overlap) was performed with a 800 nm diode laser
(LightSheer, Lumenis, Yokneam, Israel). The skin was serially
cut in vertical sections and stained with hematoxylin and
eosin and nitro-blue tetrazolium chloride (Neumann et al.,
1991).
Treatment was also performed in a live pig, with approval
from MGH institutional animal care and use committee
(IACUC). Flank hair was wax epilated with wax strips (NAD’s,
Garden Grove, CA), and the particle suspension was applied,
massaged, and laser irradiated.
Computational model of fluence distribution, optical
absorption, and thermal tissue injury
A conservative estimate of particle concentration in the
follicle was used, as 3% of the applied concentration. Details
of the calculations are provided in Supplementary Information
online.
Biodistribution and skin safety studies in an in vivo porcine
model
An IACUC approved study was performed in two swine to
assess gold particle distribution in the skin and other organs
following two treatments at 3-week interval. Hair from the
flank was epilated. Particle suspension (4 ml) was applied
over 255 cm2 and massaged for ten minutes. The skin was
cleaned with gauze to remove surface particles. Irradiation
was performed in two passes with ~ 10% overlap. One animal
was euthanized 1 month following Treatment 2 and the other
animal 2 months following Treatment 2. Follow-ups were
performed at 14 days, 1 month, and 2 months (for animal 2).
Punch biopsies were taken to quantify gold via Neutron
Activation Analysis (De Soete et al., 1972). At necropsy,
biopsies of tissues from liver, kidneys, adrenal glands, spleen,
heart, mesentery lymph nodes, pancreas, lungs, and brain were
harvested for histopathology and Neutron Activation Analysis.
Histopathology after treatment of post- and pre-auricular in vivo
human skin
Seventeen subjects were enrolled in an IRB (IntegReview,
Austin, TX) approved study at two sites (New York, NY and
Youngstown, OH). Each subject underwent a treatment in two
bilateral post- or pre-auricular areas. Inclusion criteria were
both genders, 18–40 years age, mild-to-moderate acne on
face in last 6 months, and Fitzpatrick skin phototype I–III. A
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Figure 3. (a) Graph from Trial 1 showing a mean percent reduction in
inflammatory lesion count from baseline for immediate treatment and control
arms up to 12 weeks post baseline. Number of subjects (N) at each time point
are also shown. Mean change is also plotted for the subjects in the immediate-
treatment arm up to 28 weeks post baseline. The bars represent the standard
error of the mean. (b) Graph from Trial 2 with a mean percent reduction in
inflammatory lesion count from baseline for the treatment and control arms.
The bars represent the standard errors of the mean. Note that the control
groups for the two trials received different kinds of sham treatments. The
individual points are joined by a line for better visualization of temporal
evolution of lesion count reduction in both graphs.
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square area of 2× 2mm was cleansed, and the gold
microparticle suspension was massaged for 4 minutes. After
wiping with a wet gauze, the skin was treated with Lumenis
LightSheer (800 nm wavelength, 9x9mm spot, ~ 10% over-
lap, 40–50 J cm− 2, average 42.8 J cm− 2, 30 milliseconds
pulse duration, two passes). Punch biopsies (3–4mm) were
obtained within 15 minutes of treatment and stained with
hematoxylin and eosin. Results of 32 evaluable specimens
were available. Serial sectioning was performed, and each
follicle in the sample was assessed for thermal damage to the
infundibulum and sebaceous gland. The frequency of injury
to each was computed. The depth of the deepest portion of
thermal damage was also recorded.
Trial 1: Randomized, controlled clinical trial of facial acne
This was an Ethics Committee approved (Clinicaltrials.gov
identifier NCT02219074) prospective, randomized, con-
trolled clinical pilot study of up to 50 subjects, designed to
test safety and efficacy of particulate delivery and laser in
treatment of facial acne, conducted at two sites. A total of 48
subjects were enrolled with written informed consent.
Inclusion criteria were both genders, 16–35 years age,
moderate-to-severe inflammatory facial acne, IGA (scale from
(Solodyn, 2006)) scores 3–4 with at least 25 total papules and
pustules present on face, and Fitzpatrick skin phototype I–III.
Key exclusion criteria were systemic medications for acne,
oral retinoid therapy, or treatment with Intense Pulsed Lights
or lasers within the past 12 months. Subjects were
randomized after entry to receive either control or treatment.
Subjects in the treatment arm received three treatments at
2-week interval, whereas subjects randomized to control arm
followed a standardized cleansing routine with a non-
prescription face wash for 12 weeks. At baseline (Treatment
1 day), lesion counts, IGA score assessment, and photography
were performed. Digital photographs were taken with a
stereotactic device (Twin-flash Nikon D90, Canfield Scien-
tific, Fairfield, NJ). Forty eight subjects (37 females) were
enrolled, 23 were randomized to treatment and 25 to control.
Mean age was 21.2 years (range 16–30). At baseline, mean
inflammatory lesion count was 41 (38 subjects with IGA 3, 10
with IGA 4). On treatment days, face was washed and 3ml of
particle suspension was massaged as described above for
10 minutes. Superficial suspension was wiped; two laser
passes were performed with a 9× 9mm handpiece with
contact cooling and ~ 10% overlap. The mean laser radiant
exposure was 33.5 J cm− 2. Pain was assessed on a scale of
0–10. Erythema, edema, and other observations were noted at
baseline, after treatment, and 8, 12, and 16 weeks post
baseline. Lesion counts were performed “live” by unblinded
assessors. Effectiveness was assessed by changes in inflam-
matory acne lesion counts at 12 weeks (post Treatment 1)
from baseline in the treatment arm compared with control.
Figure 4. Baseline (top row) and 24-week post-baseline (bottom row) photographs of a subject in the treated arm from Trial 1 showing a reduction in
inflammatory lesion burden on the cheeks. Subject gave permission to have her de-identified images published.
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Follow-ups up to 28 weeks post baseline were conducted for
treatment arm subjects to understand durability. The flowchart
is provided in Figure 5a.
Trial 2: Randomized, controlled clinical trial of facial acne
Trial 2 (Clinicaltrials.gov identifier NCT02219074) was a
separate, independent Ethics Committee approved study in
which the sites and inclusion/exclusion criteria were
unchanged from Trial 1. The principal differences were
treatment regimen and choice of control. Subjects in the
‘active treatment’ arm were treated three times, 1 week apart;
mean laser radiant exposure was 33.4 J cm− 2. Subjects in the
‘sham’ arm were treated similarly, but instead of the
microparticle suspension vehicle (without light-absorbing
particles) was used with a fluence of 10 J cm−2. The use of
a lower fluence in the sham-arm is a limitation of the study.
Fifty-one subjects (37 females) were enrolled with 27 in the
active treatment arm. At baseline, mean inflammatory lesion
count was 44.8 and mean age was 21.4 (range 16–26). Thirty-
seven subjects had IGA 3; 14 had IGA 4. Observations were
made at baseline, after treatment, and 8, 12, and 16 weeks
post baseline. The flowchart is provided in Figure 5b.
Lesion counts and IGA scores were performed “live” by
unblinded assessors, and, in parallel, by a single blinded
reviewer (also “live” and unaware of the assignment to groups)
at each site to assess bias (if any). High correlation between
blinded and unblinded assessment (r=0.95) was noted. Thus,
data pooled from all five unblinded investigators assessments
are reported as these same five investigators conducted
assessments in the prior study eliminating intra-rater variability
that might otherwise be introduced if using the different, albeit
blinded, investigator assessments. Percent change in inflam-
matory lesion count from baseline as well as a fraction of
subjects showing improvement in IGA score of two or better
were compared in the two arms. Response rate calculation
(positive response upon 50% or higher reduction in inflam-
matory lesions) was performed at each follow-up point.
Statistical analysis for clinical studies
For Trial 1, the population was all subjects completing the
specified treatment regimen and being evaluated (lesion
counting, IGA) at 12 weeks from baseline without noteworthy
protocol violations. Safety population was all subjects receiv-
ing sham or active treatment. For each group, inflammatory
lesion counts were summarized using descriptive statistics at
baseline and Week 12 from baseline, and absolute inflamma-
tory lesion count changes were summarized at Week 12 from
baseline, which were adjusted for multiple imputation. Safety
was evaluated by describing Adverse Events throughout the
study. The analysis for Trial 2 differed slightly; percent change
in inflammatory lesion count was used.
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